Moderna, Inc.

We are mRNA. And mRNA is us.

Every day, we come together to create the blueprints needed to fight and eradicate diseases, and to help people live healthier lives. And the world has witnessed the powerful benefits of our platform technology.

With mRNA technology, we are completely reimagining how medicines are created and delivered. And in the process, we’re launching an entirely new industry, one fueled by deep care for our teams as well as for others.

Through the power of mRNA, we’re giving our people a platform to change medicine—and an opportunity to change the world.

Come with us as we pursue the uncharted reaches of possibility and make your mark on the future of medicine: modernatx.com/careers

200 Technology Square
Cambridge, MA

Tel: 617-714-6500

Visit website

Email Us

Stock Symbol: MRNA
Stock Exchange: USNASDAQ GS

Changing the future of medicine starts with our people. Across Moderna, our colleagues are working to make the impossible possible, and our goal is to support them every step of the way. With a global team and a unique culture, driven by the company’s values and mindsets, Moderna’s mission is to deliver the greatest possible impact to people through mRNA medicines.

Every Role Matters, Enabling Transformative Mission

At Moderna, our changemakers are actively building a better future, one innovation at a time. We recently asked Keke if she could create a six-word story about what being a changemaker meant to her.

Read Keke’s Story

Take your moment with benefits

We know that you will give us your all and we want to make sure that we’re doing the same for you and the people closest to you. We’re on this incredible journey of pushing past the possible together, which is why we provide paramount support for both you and your family.

Learn More

NEWS

Drug Development

Vaccine Manufacturers Practicing for Worse COVID-19 Variants to Emerge

Winter is quickly approaching in the U.S. Vaccine makers aren’t taking a wait-and-see approach but actively preparing for what may come next.

October 21, 2021

3 min read

Kate Goodwin

Biotech Bay

ReCode Scores $80 Million to Advance mRNA-Based Cystic Fibrosis, PCD Programs

ReCode is aiming to advance its lead candidates for cystic fibrosis and primary ciliary dyskinesia (PCD).

October 21, 2021

4 min read

Alex Keown

Pictured: Gloved hand holding syringe in front of

BioCapital

Manufacturing Issues Deliver More Delays for Novavax’s COVID-19 Vaccine

Novavax is having problems getting its COVID-19 vaccine to the finish line. Shares plunged more than 23% in premarket trading today after reports that it is having manufacturing problems.

October 20, 2021

3 min read

Mark Terry

Policy

Covid News Brief: Vaccine Boosters, Profits, Treatment Updates and More

With expectations that the U.S. FDA will announce a decision about booster shots for the Moderna and Johnson & Johnson vaccines this week, there is plenty of COVID-19-related news. Here’s a look.

October 19, 2021

5 min read

Mark Terry

Genetown

Is mRNA the Future of Drug Development?

The idea of using mRNA has been around for some time, but only in recent years has it become practical. The COVID-19 pandemic provided the opportunity for the technology to push ahead.

October 19, 2021

5 min read

Mark Terry

Drug Development

Moderna Panel Vote Near Carbon Copy of Pfizer’s

The news of a unanimous decision by the adcom came just two days after the agency issued a 45-page document that contained vague comments on the drug.

October 15, 2021

2 min read

Vanessa Doctor, RN

Drug Development

COVID Update: Mixing COVID-19 Vaccines Safe and Effective; Biden Presses Moderna

As the FDA prepares to discuss booster shots for Moderna and J&J vaccines, a new study came out suggesting that mixing and matching vaccines works well and is safe.

October 14, 2021

4 min read

Mark Terry